BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30130147)

  • 1. A Prospective Study of L-Dex Values in Breast Cancer Patients Pretreatment and Through 12 Months Postoperatively.
    Ridner SH; Dietrich MS; Spotanski K; Doersam JK; Cowher MS; Taback B; McLaughlin S; Ajkay N; Boyages J; Koelmeyer L; DeSnyder S; Shah C; Vicini F
    Lymphat Res Biol; 2018 Oct; 16(5):435-441. PubMed ID: 30130147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Bioimpedance Spectroscopy with Risk Factors for the Development of Breast Cancer-Related Lymphedema.
    Vicini F; Shah C; Whitworth P; Walker M; Shi J
    Lymphat Res Biol; 2018 Dec; 16(6):533-537. PubMed ID: 30133336
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioimpedance spectroscopy is not associated with a clinical diagnosis of breast cancer-related lymphedema.
    Spitz JA; Chao AH; Peterson DM; Subramaniam V; Prakash S; Skoracki RJ
    Lymphology; 2019; 52(3):134-142. PubMed ID: 31874125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
    Kaufman DI; Shah C; Vicini FA; Rizzi M
    Breast Cancer Res Treat; 2017 Dec; 166(3):809-815. PubMed ID: 28831632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective Validation Study of Bioimpedance with Volume Displacement in Early-Stage Breast Cancer Patients at Risk for Lymphedema.
    Barrio AV; Eaton A; Frazier TG
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(0 3):S370-5. PubMed ID: 26085222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study.
    Soran A; Ozmen T; McGuire KP; Diego EJ; McAuliffe PF; Bonaventura M; Ahrendt GM; DeGore L; Johnson R
    Lymphat Res Biol; 2014 Dec; 12(4):289-94. PubMed ID: 25495384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines.
    Shah C; Whitworth P; Valente S; Schwarz GS; Kruse M; Kohli M; Brownson K; Lawson L; Dupree B; Vicini FA
    Breast Cancer Res Treat; 2023 Feb; 198(1):1-9. PubMed ID: 36566297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis.
    Ridner SH; Dietrich MS; Cowher MS; Taback B; McLaughlin S; Ajkay N; Boyages J; Koelmeyer L; DeSnyder SM; Wagner J; Abramson V; Moore A; Shah C
    Ann Surg Oncol; 2019 Oct; 26(10):3250-3259. PubMed ID: 31054038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative Lymphedema-Related Risk Factors in Early-Stage Breast Cancer.
    Iyigun ZE; Duymaz T; Ilgun AS; Alco G; Ordu C; Sarsenov D; Aydin AE; Celebi FE; Izci F; Eralp Y; Ozmen V
    Lymphat Res Biol; 2018 Feb; 16(1):28-35. PubMed ID: 28346852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of perometry-based volumetric arm measurements and bioimpedance spectroscopy for early identification of lymphedema in a prospectively-screened cohort of breast cancer patients.
    Gillespie TC; Roberts SA; Brunelle CL; Bucci LK; Bernstein MC; Daniell KM; Naoum GN; Miller CL; Taghian AG
    Lymphology; 2021; 54(1):1-11. PubMed ID: 34506083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is bioimpedance spectroscopy a useful tool for objectively assessing lymphovenous bypass surgical outcomes in breast cancer-related lymphedema?
    Sutherland A; Wagner JL; Korentager S; Butterworth J; Amin AL; Balanoff CR; Hangge A; Larson KE
    Breast Cancer Res Treat; 2021 Feb; 186(1):1-6. PubMed ID: 33392840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioimpedance Spectroscopy for Assessment of Breast Cancer-Related Lymphedema: A Systematic Review.
    Forte AJ; Huayllani MT; Boczar D; Ciudad P; Lu X; Kassis S; Parker AS; Moore PA; McLaughlin SA
    Plast Surg Nurs; 2020; 40(2):86-90. PubMed ID: 32459756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Cancer-Related Lymphedema (BCRL) and Bioimpedance Spectroscopy: Long-Term Follow-Up, Surveillance Recommendations, and Multidisciplinary Risk Factors.
    Jeffers EJ; Wagner JL; Korentager SS; Larson KE; Balanoff CR; Baker J; Chollet-Hinton L; Kilgore LJ
    Ann Surg Oncol; 2023 Oct; 30(10):6258-6265. PubMed ID: 37535267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue Dielectric Constant Measures in Women With and Without Clinical Trunk Lymphedema Following Breast Cancer Surgery: A 78-Week Longitudinal Study.
    Koehler LA; Mayrovitz HN
    Phys Ther; 2020 Aug; 100(8):1384-1392. PubMed ID: 32379872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.
    Kilgore LJ; Korentager SS; Hangge AN; Amin AL; Balanoff CR; Larson KE; Mitchell MP; Chen JG; Burgen E; Khan QJ; O'Dea AP; Nye L; Sharma P; Wagner JL
    Ann Surg Oncol; 2018 Oct; 25(10):2948-2952. PubMed ID: 29987599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparison of Bioimpedance Spectroscopy or Tape Measure Triggered Compression Intervention in Chronic Breast Cancer Lymphedema Prevention.
    Ridner SH; Dietrich MS; Boyages J; Koelmeyer L; Elder E; Hughes TM; French J; Ngui N; Hsu J; Abramson VG; Moore A; Shah C
    Lymphat Res Biol; 2022 Dec; 20(6):618-628. PubMed ID: 35099283
    [No Abstract]   [Full Text] [Related]  

  • 17. Breast cancer-related lymphedema after axillary lymph node dissection: does early postoperative prediction model work?
    Soran A; Menekse E; Girgis M; DeGore L; Johnson R
    Support Care Cancer; 2016 Mar; 24(3):1413-9. PubMed ID: 26349574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention.
    Koelmeyer LA; Gaitatzis K; Dietrich MS; Shah CS; Boyages J; McLaughlin SA; Taback B; Stolldorf DP; Elder E; Hughes TM; French JR; Ngui N; Hsu JM; Moore A; Ridner SH
    Cancer; 2022 Sep; 128(18):3408-3415. PubMed ID: 35797441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing chronic breast cancer-related lymphedema utilizing a program of prospective surveillance with bioimpedance spectroscopy.
    Whitworth PW; Cooper A
    Breast J; 2018 Jan; 24(1):62-65. PubMed ID: 29063664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive review of bioimpedance spectroscopy as a diagnostic tool for the detection and measurement of breast cancer-related lymphedema.
    Seward C; Skolny M; Brunelle C; Asdourian M; Salama L; Taghian AG
    J Surg Oncol; 2016 Oct; 114(5):537-542. PubMed ID: 27393376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.